DCTH Company Profile and Key Details

DCTH has shown mixed momentum, losing -0.97% over the past week and -14.87% over the past quarter, though year-to-date performance is up 0.89%. Short-term trend indicators are bullishly aligned (SMA20 -4.99%, SMA50 -6.49%, SMA200 -17.63%). The stock’s 14-day RSI is 43.61 (neutral), while the ATR of 0.49 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -48.44% below its high and over 15.76% above its low. Average 10-day trading volume of 462.51 thousand shares is below the 3-month average of 555.62 thousand, indicating normal recent market interest.

Delcath Systems, Inc. has 34.98 million shares outstanding. The public float is 34.03 million shares, elevated short interest at 8.85% of float. This equals 3.04 million shares. The short ratio is 3.97 days. Institutional investors hold 54.23% of the float. Insiders own 2.72%. SALAMON STEVEN A J holds 1.12 million shares, Aharon Gil has 1.07 million shares and Rosalind Advisors, Inc. has 836.13 thousand shares. Over the past six months, insider transactions show net buying. They sold 0.00 shares across 0 transactions.

Delcath Systems, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$3.80. This means the shares are trading below this model’s fair value.

Delcath Systems, Inc. generated EPS of $0.01 over the past year. Five-year average earnings growth is 69.36%. The latest quarter delivered EPS of $0.02. The next quarter is forecast at -$0.06. Next year's EPS is expected at $60.38. Analyst sentiment is bullish. Analyst rating data shows there are 2 Strong Buy ratings, 6 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $31.00 to $18.00. The high target offers 227.0% upside. The low target suggests 89.87% downside. The mean target is $25.25. This offers 166.35% upside. Delcath Systems, Inc. earnings surprise history is a mixed track record. The quarter that ended November 04, 2025, missed forecasts by 3.6%. The prior quarter beat by 169.23%. Over the last six quarters, Apple has recorded several small beats. These include 41.18% in August 05, 2024.

Delcath Systems, Inc. (NASDAQ:DCTH) closed at $9.48 USD, gaining $0.08 (0.85%) from the previous close of $9.40. The stock is currently mid-range between its 52-week high and low $8.12 and $18.23. With a market capitalization of about $328.96 million, Delcath Systems, Inc. is classified as a small-cap and shows lower-than-market volatility (beta ~0.36). Key stats such as the average daily volume over the past year has been around 571.78 thousand shares, volume is running light vs its 52-week average. Headquartered in New York City, NY, Delcath Systems, Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Gerard J. Michel, the company employs approximately 96 people and listed since May 03, 2018. Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe.

Delcath Systems, Inc. (NASDAQ:DCTH) shares are flat 0.89% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Delcath Systems, Inc. trading at a premium to the broader market with a P/E of 286.19. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $22.23, suggesting 134.49% upside. Our AI forecast model points to short-term weakness (-8.12% over two weeks), a medium-term fall (-28.16% over three months), and a longer-term loss (-17.19% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Delcath Systems, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -8.12%, with price expected at $8.71 by March 04, 2026, within a range of $8.40 to $9.03 3-Month Outlook: Projected fall of -28.16%, reaching $6.81 by May 18, 2026, with a range of $6.50 to $7.10. 1-Year Outlook: Projected loss of -17.19%, with price at $7.85 by February 18, 2027, within a range of $1.76 to $8.74.

Delcath Systems, Inc. trades at a P/E ratio of 286.19, slightly above the S&P 500 average, with a price-to-sales ratio of 4.11 and a price-to-book ratio of 2.99 suggesting the stock is closer to book value. The P/FCF stands at 27.17, also above market averages.